Location History:
- San Diego, CA (US) (1998 - 2001)
- Del Mar, CA (US) (2000 - 2001)
- La Jolla, CA (US) (1997 - 2002)
- Solano Beach, CA (US) (2013)
Company Filing History:
14 out of 1,187 
1 out of 832,880 Years Active: 1997-2013
Title: Unveiling the Innovations of Renowned Inventor Carlos F. Barbas
Introduction:
Carlos F. Barbas, a distinguished inventor in the field of biotechnology, hails from Del Mar, CA (US). With an impressive track record of 15 patents to his name, his contributions have significantly impacted the realm of integrin-specific antibodies and peptides.
Latest Patents:
In his latest patents, Carlos F. Barbas introduces cutting-edge advancements in the domain of integrin αβspecific antibodies and peptides. These novel inventions exhibit minimal immunoreactivity with other integrins, showcasing their precision and efficacy. Moreover, he presents innovative methods for inhibiting platelet aggregation, offering promising avenues for therapeutic interventions. Additionally, his work on heterodimeric receptor libraries using phagemids represents a pioneering approach in the development of antigenously assembling receptors.
Career Highlights:
Carlos F. Barbas has made substantial contributions during his tenure at The Scripps Research Institute, where his groundbreaking research has paved the way for transformative discoveries in biotechnology. His innovative approach towards developing integrin-specific therapies has garnered acclaim within the scientific community, positioning him as a trailblazer in the field.
Collaborations:
Throughout his illustrious career, Carlos F. Barbas has collaborated with esteemed colleagues such as Richard A. Lerner and Angray Singh Kang. These collaborative efforts have synergized expertise, leading to the creation of groundbreaking technologies and methodologies that have redefined the landscape of biotechnological innovation.
Conclusion:
In conclusion, Carlos F. Barbas stands as a luminary in the field of biotechnology, with a remarkable portfolio of patents that underscore his unwavering dedication to innovation and scientific advancement. His seminal contributions to integrin-specific antibodies and peptides have revolutionized the field, offering new possibilities for therapeutic interventions and research endeavors.